60¢sixtycents

Bristol-Myers Squibb CompanyBMY

$54.00-1.28 (-2.32%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$110B
Large-cap
-8%
2016 — today
10-Year Price
-24%
2016 — today
52-Week Range
$42.60$62.37
Current $54.00· 58%

Bristol-Myers Squibb researches, develops, and commercializes a global biopharmaceutical portfolio spanning hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases. Key therapies include Revlimid, Eliquis, Opdivo, Pomalyst/Imnovid, Orencia, Sprycel, Yervoy, Abraxane, Reblozyl, Empliciti, Zeposia, Breyanzi, Inrebic, and Onureg. Products are distributed worldwide via wholesalers, pharmacies, hospitals, and clinics. Established in 1887, it is based in New York.

Valuation in context

P/E ratio
15.2
Below average
Below the 10-year average
P/B ratio
5.5
Above average
Pricier than usual over the last 10 years
EV / EBITDA
10.6
Below average
Below the 10-year average
Dividend Yield
4.6%
Historically high
Historically high relative to the last 10 years
FCF Yield
10.8%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when BMY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.